We are live on
!
Find out more
CC
Centiva Capital Portfolio holdings
AUM
$11.5B
1-Year Est. Return
31.97%
This Fund
S&P 500
This Quarter
Est. Return
+6.42%
1 Year Est. Return
+31.97%
3 Year Est. Return
+65.13%
5 Year Est. Return
+86.06%
10 Year Est. Return
–
AUM
$4.07B
AUM Growth
+$533M
(+15%)
Cap. Flow
+$397M
Cap. Flow
% of AUM
9.75%
Top 10 Holdings %
Top 10 Hldgs %
23.34%
Holding
2,059
New
723
Increased
305
Reduced
286
Closed
588
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$60.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.5M |
| 3 |
Brookfield
BN
|
+$38.3M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$37.9M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$30.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$19.1M |
| 2 |
FPAC
Far Peak Acquisition Corporation
FPAC
|
+$14.8M |
| 3 |
DRAY
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
|
+$14.4M |
| 4 |
Apple
AAPL
|
+$13.5M |
| 5 |
Tesla
TSLA
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.97% |
| 2 | Financials | 12.8% |
| 3 | Industrials | 4.19% |
| 4 | Technology | 3.82% |
| 5 | Healthcare | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Recursion Pharmaceuticals
RXRX
$1.79B
| $90.8K | ﹤0.01% |
+13,618
| New | +$108K |
|
1327
RPC Inc
RES
$1.42B
| $88.7K | ﹤0.01% |
11,528
+221
| +2% | +$1.97K |
|
1328
Pitney Bowes
PBI
$2.36B
| $88.1K | ﹤0.01% |
+22,637
| New | +$95.1K |
|
|
MAXR
1329
PUT
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $86.8K | ﹤0.01% |
1,700
| – | – |
|
|
EB
1330
DELISTED
Eventbrite
EB
| $86.7K | ﹤0.01% |
+10,109
| New | +$83.4K |
|
|
INN
1331
Summit Hotel Properties
INN
$654M
| $85K | ﹤0.01% |
+12,149
| New | +$92.2K |
|
1332
Scilex Holding
SCLX
$38.2M
| $83.6K | ﹤0.01% |
+291
| New | +$80.7K |
|
1333
CALL
Teva Pharmaceuticals
TEVA
$42.5B
| $79.7K | ﹤0.01% |
+9,000
| New | +$89K |
|
|
1334
PUT
Teva Pharmaceuticals
TEVA
$42.5B
| $79.7K | ﹤0.01% |
+9,000
| New | +$89K |
|
|
WW
1335
DELISTED
WW International
WW
| $78.5K | ﹤0.01% |
+19,046
| New | +$83.3K |
|
1336
Regis Corp
RGS
$67.8M
| $77.3K | ﹤0.01% |
+3,482
| New | +$96.2K |
|
1337
Netflix
NFLX
$340B
| $75.7K | ﹤0.01% |
2,190
-12,460
| -85% | -$412K |
|
|
ALLG
1338
DELISTED
Allego N.V.
ALLG
| $68.7K | ﹤0.01% |
+28,520
| New | +$104K |
|
|
RWT
1339
Redwood Trust
RWT
$580M
| $68.3K | ﹤0.01% |
10,130
-3,076
| -23% | -$23K |
|
|
VMEO
1340
DELISTED
Vimeo
VMEO
| $67.7K | ﹤0.01% |
+17,670
| New | +$69.3K |
|
1341
Ouster
OUST
$2.5B
| $65.9K | ﹤0.01% |
+7,848
| New | +$91K |
|
1342
Freeport-McMoran
FCX
$110B
| $65.7K | ﹤0.01% |
1,605
-12,775
| -89% | -$531K |
|
|
INFN
1343
DELISTED
Infinera Corporation Common Stock
INFN
| $65.6K | ﹤0.01% |
+8,453
| New | +$61.5K |
|
1344
Goldgroup Mining
GORO
$492M
| $64.2K | ﹤0.01% |
+61,106
| New | +$78.1K |
|
1345
Advanced Micro Devices
AMD
$760B
| $61.3K | ﹤0.01% |
625
-74,325
| -99% | -$6.05M |
|
1346
PUT
International Paper
IP
$20.8B
| $57.7K | ﹤0.01% |
+1,600
| New | +$59.3K |
|
1347
uniQure
QURE
$3.38B
| $55.1K | ﹤0.01% |
2,738
-162
| -6% | -$3.4K |
|
1348
Oracle
ORCL
$435B
| $55K | ﹤0.01% |
+592
| New | +$51.9K |
|
|
HZNP
1349
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $54.6K | ﹤0.01% |
500
-54,500
| -99% | -$6.02M |
|
1350
APA Corp
APA
$14.9B
| $53.8K | ﹤0.01% |
+1,491
| New | +$59.8K |
|
Similar funds
MG
RCM
WAM
AAIS
AI
BMSSC
HTC
GJL
Centiva Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Centiva Capital held 2,059 positions worth $4.07B, up 15% from $3.54B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Centiva Capital deployed $397M of net new capital in Q1 2023, opening 723 new positions and adding to 305 existing holdings. Its largest new stake was Invesco QQQ Trust: 205,840 shares worth $66.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, down from 73% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Apple, an estimated $13.5M trimmed.
- Centiva Capital's largest Q1 2023 buy was Invesco QQQ Trust: 205,840 shares worth $66.1M.
- Centiva Capital added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $44.5M increase.
- Centiva Capital's biggest Q1 2023 reduction was Apple, cutting an estimated $13.5M.
- Centiva Capital fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q1 2023, selling an estimated $19.1M.
- Centiva Capital's ten largest holdings make up 23% of its $4.07B portfolio in Q1 2023.
- Centiva Capital opened 723 new positions and closed 588 in Q1 2023.
- Centiva Capital's portfolio value rose 15% quarter-over-quarter to $4.07B.
Based on Centiva Capital's 13F filing for Q1 2023, filed 15 May 2023.